Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 17134957)

Published in Nutr Metab Cardiovasc Dis on June 27, 2006

Authors

Stefan Branth1, Gunnar Ronquist, Mats Stridsberg, Leif Hambraeus, Erik Kindgren, Roger Olsson, David Carlander, Bengt Arnetz

Author Affiliations

1: Department of Medical Sciences, Section of Nutrition, University of Uppsala, University Hospital of Uppsala, SE-751 85 Uppsala, Sweden. stefan.branth@medsci.uu.se <stefan.branth@medsci.uu.se>

Articles citing this

Dynamic body weight and body composition changes in response to subordination stress. Physiol Behav (2007) 1.24

Associations between police officer stress and the metabolic syndrome. Int J Emerg Ment Health (2011) 1.09

Prevalence of metabolic syndrome in Iranian professional drivers: results from a population based study of 12,138 men. PLoS One (2012) 0.95

Meal patterns and hypothalamic NPY expression during chronic social stress and recovery. Am J Physiol Regul Integr Comp Physiol (2010) 0.93

Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress. Am J Physiol Regul Integr Comp Physiol (2009) 0.91

Long work hours and adiposity among police officers in a US northeast city. J Occup Environ Med (2012) 0.89

Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy. Am J Physiol Regul Integr Comp Physiol (2010) 0.84

Late-life coronary heart disease mortality of Finnish war veterans in the TAMRISK study, a 28-year follow-up. BMC Public Health (2011) 0.83

Associations between Psychological Distress and Body Mass Index among Law Enforcement Officers: The National Health Interview Survey 2004-2010. Saf Health Work (2013) 0.82

Metabolic stress-like condition can be induced by prolonged strenuous exercise in athletes. Ups J Med Sci (2009) 0.78

Elevated corticosterone in the dorsal hindbrain increases plasma norepinephrine and neuropeptide Y, and recruits a vasopressin response to stress. Am J Physiol Regul Integr Comp Physiol (2014) 0.77

Hypoglycemia: A Possible Link between Insulin Resistance, Metabolic Dyslipidemia, and Heart and Kidney Disease (the Cardiorenal Syndrome). Cardiorenal Med (2011) 0.77

Circadian Clocks and the Interaction between Stress Axis and Adipose Function. Int J Endocrinol (2015) 0.75

Hypothalamic-pituitary-adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women. Endocrine (2014) 0.75

Association of metabolic syndrome and albuminuria with cardiovascular risk in occupational drivers. Int J Mol Sci (2013) 0.75

Articles by these authors

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation (2003) 4.31

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol (2003) 2.36

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci U S A (2011) 2.14

Living with conflicts-ethical dilemmas and moral distress in the health care system. Soc Sci Med (2004) 1.93

Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68

Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One (2012) 1.67

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol (2002) 1.59

Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet (2004) 1.58

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. J Am Coll Cardiol (2005) 1.57

Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis. J Am Soc Nephrol (2009) 1.55

Hand-assisted retroperitoneoscopic live donor nephrectomy in comparison to open and laparoscopic procedures: a prospective study on donor morbidity and kidney function. Transplantation (2004) 1.49

Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study. Intensive Care Med (2012) 1.48

Somatostatin receptor expression in non-medullary thyroid carcinomas. Hormones (Athens) (2012) 1.43

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience. Semin Nucl Med (2002) 1.40

Serum levels of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect (2003) 1.33

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation (2007) 1.32

Lessons from the recent Journal Citation Report figures. Ups J Med Sci (2010) 1.18

Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Peptides (2003) 1.14

Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant (2007) 1.12

Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure. Circulation (2008) 1.12

Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease. ACS Chem Neurosci (2013) 1.10

Endocrine measures of stress and self-rated health: a longitudinal study. J Psychosom Res (2003) 1.07

Measuring moral distress in pharmacy and clinical practice. Nurs Ethics (2006) 1.07

Immune cell counts and risks of respiratory infections among infants exposed pre- and postnatally to organochlorine compounds: a prospective study. Environ Health (2008) 1.07

Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. J Am Coll Cardiol (2008) 1.05

Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer. Mol Pharmacol (2006) 1.03

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors. Neuroendocrinology (2009) 1.03

Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J Histochem Cytochem (2004) 1.03

Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol (2012) 1.02

Why do nurses at a university hospital want to quit their jobs? J Nurs Manag (2005) 1.01

Endocrine responses to nocturnal eating--possible implications for night work. Eur J Nutr (2003) 1.01

Sleep after mobile phone exposure in subjects with mobile phone-related symptoms. Bioelectromagnetics (2011) 1.01

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment. J Alzheimers Dis (2012) 0.99

Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. Prostate (2002) 0.99

A substantial increase of the impact factor. Ups J Med Sci (2012) 0.98

Granins and granin-related peptides in neuroendocrine tumours. Regul Pept (2010) 0.98

Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab (2004) 0.97

Human prostasomes contain chromosomal DNA. Prostate (2009) 0.96

Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study. Pediatr Pulmonol (2003) 0.96

Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in rat basophilic leukemia mast cells and Jurkat T cells. J Immunol (2002) 0.96

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours. Eur J Endocrinol (2004) 0.96

Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility. Cancer Control (2006) 0.95

Neuro- and cardioprotective effects of blockade of nitric oxide action by administration of methylene blue. Ann N Y Acad Sci (2007) 0.94

Associations between CB-153 and p,p'-DDE and hormone levels in serum in middle-aged and elderly men. Chemosphere (2006) 0.94

The impact of organisational settings on physician wellbeing. Int J Health Care Qual Assur (2007) 0.94

Energy metabolic changes in the early post-injury period following traumatic brain injury in rats. Neurochem Res (2006) 0.94

Role of exosomes in myocardial remodeling. Circ Res (2014) 0.93

Natriuretic peptides in unstable coronary artery disease. Eur Heart J (2004) 0.93

Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Exp Gerontol (2008) 0.93

Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens (2010) 0.93

Metabolic responses to nocturnal eating in men are affected by sources of dietary energy. J Nutr (2002) 0.93

An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet (2007) 0.92

Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf (2004) 0.92

A randomized clinical trial of the treatment effects of massage compared to relaxation tape recordings on diffuse long-term pain. Psychother Psychosom (2003) 0.91

Prostasomal DNA characterization and transfer into human sperm. Mol Reprod Dev (2011) 0.91

Pain, disability and coping reflected in the diurnal cortisol variability in patients scheduled for lumbar disc surgery. Eur J Pain (2008) 0.91

POP levels in breast milk and maternal serum and thyroid hormone levels in mother-child pairs from Uppsala, Sweden. Environ Int (2009) 0.91

"We are white coats whirling round"--moral distress in Swedish pharmacies. Pharm World Sci (2005) 0.91

Prostasomes are heterogeneous regarding size and appearance but affiliated to one DNA-containing exosome family. Prostate (2012) 0.90

Downsizing within a hospital: cutting care or just costs? Soc Sci Med (2003) 0.90

Self-rated health, life-style, and psychoendocrine measures of stress in healthy adult women. Ups J Med Sci (2010) 0.89

Identification of the first synthetic steroidogenic factor 1 inverse agonists: pharmacological modulation of steroidogenic enzymes. Mol Pharmacol (2007) 0.89

Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study. Pancreas (2003) 0.89

Resilience as a protective factor against the development of psychopathology among refugees. J Nerv Ment Dis (2013) 0.89

Characteristics of human prostasomes isolated from three different sources. Prostate (2003) 0.89

Proteomic analysis of prostate cancer metastasis-derived prostasomes. Anticancer Res (2010) 0.88

Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain (2010) 0.88

A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Endocr Relat Cancer (2007) 0.88

Identification and characterization of novel small-molecule protease-activated receptor 2 agonists. J Pharmacol Exp Ther (2008) 0.88

Synthesis of 2-substituted pyridines via a regiospecific alkylation, alkynylation, and arylation of pyridine N-oxides. Org Lett (2007) 0.88

More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report. J Med Food (2007) 0.88

Growth factor stimulation of cardiomyocytes induces changes in the transcriptional contents of secreted exosomes. J Extracell Vesicles (2013) 0.87

Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis. Bioorg Med Chem Lett (2009) 0.87

Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). J Neurooncol (2006) 0.87

Pre- and post-displacement stressors and time of migration as related to self-rated health among Iraqi immigrants and refugees in Southeast Michigan. Med Confl Surviv (2011) 0.87

Chromogranin A as a determinant of midgut carcinoid tumour volume. Regul Pept (2004) 0.87

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). Am J Cardiol (2005) 0.87

Human prostasomes express glycolytic enzymes with capacity for ATP production. Am J Physiol Endocrinol Metab (2013) 0.86

Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion. Physiol Genomics (2006) 0.86

Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin Endocrinol (Oxf) (2007) 0.85

Insulin resistance after cardiopulmonary bypass in the elderly patient. Scand Cardiovasc J (2007) 0.85

Relation between physical capacity, nutritional status and systemic inflammation in COPD. Clin Respir J (2010) 0.85

Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur J Endocrinol (2009) 0.85

Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. Eur J Pharmacol (2008) 0.85

Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas. Regul Pept (2007) 0.85

Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodies. J Histochem Cytochem (2002) 0.84

Dominant prostasome immunogens for sperm-agglutinating autoantibodies of infertile men. J Androl (2004) 0.84

Microdialysis and electromyography of experimental muscle fatigue in healthy volunteers and patients with mitochondrial myopathy. Muscle Nerve (2002) 0.84

Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases. Prostate (2004) 0.84

Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack. Prostate (2005) 0.84

Performance-based reimbursement in health care. Consequences for physicians' cost awareness and work environment. Eur J Public Health (2002) 0.84

Flow cytometric technique for determination of prostasomal quantity, size and expression of CD10, CD13, CD26 and CD59 in human seminal plasma. Int J Androl (2006) 0.84

Patient participation during hospitalization for myocardial infarction: perceptions among patients and personnel. Scand J Caring Sci (2010) 0.84

The impact of management programs on physicians' work environment and health. A prospective, controlled study comparing different interventions. J Health Organ Manag (2004) 0.84

Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis. Am J Reprod Immunol (2002) 0.84

Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. J Med Chem (2009) 0.83

Neuropeptide FF receptors have opposing modulatory effects on nociception. J Pharmacol Exp Ther (2010) 0.83